UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

The lancet. Diabetes & endocrinology, 2018-06, Vol.6 (6), p.464-475

2018

Volltextzugriff (PDF)

Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

The Lancet (British edition), 2011-01, Vol.377 (9762), p.312-320

2011

Volltextzugriff (PDF)

Serum Chloride Is an Independent Predictor of Mortality in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.836-843

2013

Volltextzugriff (PDF)

Resting Heart Rate Pattern During Follow-Up and Mortality in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 2010-02, Vol.55 (2, Part 2 Suppl), p.567-574

2010

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

The unintended consequences of clinical trials regulations

PLoS medicine, 2009-11, Vol.3 (11), p.e1000131-e1000131

2009

Volltextzugriff (PDF)

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients : the VALUE trial

Journal of hypertension, 2006-07, Vol.24 (7), p.1405-1412

2006

Volltextzugriff (PDF)

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

The Lancet (British edition), 1998-07, Vol.352 (9123), p.179-184

1998

Volltextzugriff (PDF)

Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke: A Randomized, Controlled Trial

Stroke (1970), 2013-09, Vol.44 (9), p.2525-2531

2013

Volltextzugriff (PDF)

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

Journal of hypertension, 2011-05, Vol.29 (5), p.980-990

2011

Volltextzugriff (PDF)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Volltextzugriff (PDF)

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

Journal of hypertension, 2001-06, Vol.19 (6), p.1149-1159

2001

Volltextzugriff (PDF)

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

The Lancet (British edition), 2004-06, Vol.363 (9426), p.2022-2031

2004

Volltextzugriff (PDF)

Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke

Stroke (1970), 2003-11, Vol.34 (11), p.2623-2628

2003

Volltextzugriff (PDF)

Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes

European heart journal, 2016-03, Vol.37 (12), p.968-974

2016

Volltextzugriff (PDF)

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Journal of hypertension, 2008-03, Vol.26 (3), p.403-411

2008

Volltextzugriff (PDF)

Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension

Hypertension (Dallas, Tex. 1979), 2013-10, Vol.62 (4), p.698-705

2013

Volltextzugriff (PDF)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

The Lancet (British edition), 2003-04, Vol.361 (9364), p.1149-1158

2003

Volltextzugriff (PDF)

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

BMJ, 2004-03, Vol.328 (7440), p.634-640

International edition, 2004

Volltextzugriff (PDF)

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Diabetes care, 2005-05, Vol.28 (5), p.1151-1157

2005

Volltextzugriff (PDF)

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

The Lancet (British edition), 2004-06, Vol.363 (9426), p.2049-2051

2004

Volltextzugriff (PDF)

Lowering blood pressure for cardiovascular risk reduction

Journal of hypertension, 2005-04, Vol.23 Suppl 1 (1), p.S3-S8

McInnes, Gordon T

2005

Volltextzugriff (PDF)

Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort

Hypertension (Dallas, Tex. 1979), 2015-05, Vol.65 (5), p.1008-1014

2015

Volltextzugriff (PDF)

Blood Pressure Response to Patterns of Weather Fluctuations and Effect on Mortality

Hypertension (Dallas, Tex. 1979), 2013-07, Vol.62 (1), p.190-196

2013

Volltextzugriff (PDF)

Direct‐Acting Vasodilators

The journal of clinical hypertension (Greenwich, Conn.), 2011-09, Vol.13 (9), p.690-692

2011

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(234)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(137)
Humans
(127)
Male
(79)
Female
(68)
Middle Aged
(67)
Hypertension - Drug Therapy
(64)
Cardiovascular System & Cardiology
(62)
Biological And Medical Sciences
(61)
Medical Sciences
(58)
Aged
(55)
Hypertension
(53)
Peripheral Vascular Disease
(47)
Antihypertensive Agents - Therapeutic Use
(43)
Adult
(39)
Risk Factors
(34)
General & Internal Medicine
(31)
Blood Pressure
(30)
Double-Blind Method
(30)
Medicine, General & Internal
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

Serum Chloride Is an Independent Predictor of Mortality in Hypertensive Patients

Resting Heart Rate Pattern During Follow-Up and Mortality in Hypertensive Patients

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The unintended consequences of clinical trials regulations

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients : the VALUE trial

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke: A Randomized, Controlled Trial

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke

Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

Lowering blood pressure for cardiovascular risk reduction

Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort

Blood Pressure Response to Patterns of Weather Fluctuations and Effect on Mortality

Direct‐Acting Vasodilators

Suchergebnisse filtern